ArticleAnnals of internal medicine2024

Biomarker risk assessment model identified high-risk patients with cancer who benefit from thromboprophylaxis.

Sander Veldhuyzen van Zanten et al.PubMed ↗Publisher ↗

No numbers read from the abstract.